- Home
- Publications
- Publication Search
- Publication Details
Title
Cognitive decline in Parkinson disease
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 13, Issue 4, Pages 217-231
Publisher
Springer Nature
Online
2017-03-03
DOI
10.1038/nrneurol.2017.27
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
- (2016) Erika Bereczki et al. Alzheimers & Dementia
- α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
- (2016) Ilaria Guella et al. ANNALS OF NEUROLOGY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
- (2016) Anja Hviid Simonsen et al. Biomarkers in Medicine
- COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
- (2016) Diego Santos-García et al. BMC Neurology
- Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
- (2016) Juan C. Jurado-Coronel et al. CNS & Neurological Disorders-Drug Targets
- Cholinergic imaging in dementia spectrum disorders
- (2016) Roman Roy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
- (2016) Zheng Ye et al. HUMAN BRAIN MAPPING
- Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
- (2016) Brit Mollenhauer et al. JOURNAL OF NEUROCHEMISTRY
- Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging
- (2016) Wei-Che Lin et al. MEDICINE
- Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial
- (2016) Daniel Weintraub et al. MOVEMENT DISORDERS
- Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
- (2016) Sara Hall et al. MOVEMENT DISORDERS
- Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency
- (2016) Ariana P. Gatt et al. MOVEMENT DISORDERS
- Motor and nonmotor heterogeneity of LRRK2 -related and idiopathic Parkinson's disease
- (2016) Connie Marras et al. MOVEMENT DISORDERS
- Nonmotor features of Parkinson's disease subtypes
- (2016) Connie Marras et al. MOVEMENT DISORDERS
- Unravelling the nonmotor mysteries of Parkinson disease
- (2016) K. Ray Chaudhuri et al. Nature Reviews Neurology
- Cholinergic and perfusion brain networks in Parkinson disease dementia
- (2016) Sean J. Colloby et al. NEUROLOGY
- Monitoring of 30 marker candidates in early Parkinson disease as progression markers
- (2016) Brit Mollenhauer et al. NEUROLOGY
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- Review: Parkinson's disease: from synaptic loss to connectome dysfunction
- (2016) Arianna Bellucci et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models
- (2016) Wai Kin D. Ko et al. NEUROPHARMACOLOGY
- Event-related potentials and cognition in Parkinson’s disease: An integrative review
- (2016) Caroline Seer et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease
- (2016) David Mengel et al. PARKINSONISM & RELATED DISORDERS
- Non motor subtypes and Parkinson's disease
- (2016) Anna Sauerbier et al. PARKINSONISM & RELATED DISORDERS
- Lack of association between IL-10 and IL-18 gene promoter polymorphisms and Parkinson’s disease with cognitive impairment in a Chinese population
- (2016) Zhenhua Liu et al. Scientific Reports
- APOE, MAPT, and COMT and Parkinson’s Disease Susceptibility and Cognitive Symptom Progression
- (2016) Kimberly C. Paul et al. Journal of Parkinsons Disease
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
- (2016) Nicholas S. Lim et al. Annals of Clinical and Translational Neurology
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
- (2016) Lucy M. Collins et al. Frontiers in Psychiatry
- Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
- (2015) M. E. Domellöf et al. ACTA NEUROLOGICA SCANDINAVICA
- Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia
- (2015) Zhen Fan et al. Alzheimers & Dementia
- Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2015) Elijah Mak et al. BRAIN
- Correlation of EEG Slowing with Cognitive Domains in Nondemented Patients with Parkinson's Disease
- (2015) Ronan Zimmermann et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Changes in anatomical and functional connectivity of Parkinson's disease patients according to cognitive status
- (2015) Boyu Chen et al. EUROPEAN JOURNAL OF RADIOLOGY
- The efficacy of oral adenosine A2Aantagonist istradefylline for the treatment of moderate to severe Parkinson’s disease
- (2015) Ruxandra Julia Vorovenci et al. Expert Review of Neurotherapeutics
- Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease
- (2015) Joana B. Pereira et al. HUMAN BRAIN MAPPING
- Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients
- (2015) Gesine Paul et al. JOURNAL OF CLINICAL INVESTIGATION
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
- (2015) Mark Terrelonge et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Recent imaging advances in neurology
- (2015) Lorenzo Rocchi et al. JOURNAL OF NEUROLOGY
- Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
- (2015) R S Desikan et al. MOLECULAR PSYCHIATRY
- Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study
- (2015) Eugenia Mamikonyan et al. MOVEMENT DISORDERS
- Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
- (2015) Lama M. Chahine et al. MOVEMENT DISORDERS
- Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
- (2015) Alison J. Yarnall et al. MOVEMENT DISORDERS
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
- (2015) Myria Petrou et al. MOVEMENT DISORDERS
- GBAVariants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
- (2015) Ignacio F. Mata et al. MOVEMENT DISORDERS
- Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial
- (2015) Fabian J. David et al. MOVEMENT DISORDERS
- Cognitive profile ofLRRK2-related Parkinson's disease
- (2015) Sindhu Srivatsal et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
- (2015) Gordon W. Duncan et al. MOVEMENT DISORDERS
- Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease
- (2015) Neha Shah et al. MOVEMENT DISORDERS
- The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
- (2015) Gretchen O. Reynolds et al. MOVEMENT DISORDERS
- Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
- (2015) Tomoko Oeda et al. NEUROBIOLOGY OF AGING
- Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
- (2015) Sophie E. Winder-Rhodes et al. NEUROBIOLOGY OF AGING
- CSF proteins and resting-state functional connectivity in Parkinson disease
- (2015) M. C. Campbell et al. NEUROLOGY
- Longitudinal study of normal cognition in Parkinson disease
- (2015) Kara Pigott et al. NEUROLOGY
- Cognitive training in Parkinson disease
- (2015) Isabella H.K. Leung et al. NEUROLOGY
- Unfolded protein response is activated in Lewy body dementias
- (2015) Jean-Ha Baek et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
- (2015) Elvira Valera et al. Neurotherapeutics
- Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
- (2015) Ane Løvli Stav et al. PARKINSONISM & RELATED DISORDERS
- Biomarkers of cognitive decline in Parkinson's disease
- (2015) Chin-Hsien Lin et al. PARKINSONISM & RELATED DISORDERS
- Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study
- (2015) Gabriella Santangelo et al. PARKINSONISM & RELATED DISORDERS
- Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia
- (2015) Barbara Borroni et al. PARKINSONISM & RELATED DISORDERS
- Mitochondrial retrograde signaling regulates neuronal function
- (2015) Umut Cagin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 5-HT1Breceptor imaging and cognition: A positron emission tomography study in control subjects and parkinson's disease patients
- (2015) Andrea Varrone et al. SYNAPSE
- Impaired cognitive performance and hippocampal atrophy in Parkinson disease
- (2015) Demet YILDIZ et al. Turkish Journal Of Medical Sciences
- Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s Disease
- (2015) Ragnhild E. Skogseth et al. Journal of Parkinsons Disease
- The efficacy of oral adenosine A2Aantagonist istradefylline for the treatment of moderate to severe Parkinson’s disease
- (2015) Ruxandra Julia Vorovenci et al. Expert Review of Neurotherapeutics
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally
- (2014) Alexandru Hanganu et al. BRAIN
- Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2014) Cristina Nombela et al. BRAIN
- Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process
- (2014) Rafael González-Redondo et al. BRAIN
- Targeting impulsivity in Parkinson’s disease using atomoxetine
- (2014) Angie A. Kehagia et al. BRAIN
- Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
- (2014) David R. Howlett et al. BRAIN PATHOLOGY
- Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
- (2014) Agostino Chiaravalloti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparing Cerebral Perfusion in Alzheimer's Disease and Parkinson's Disease Dementia: An ASL-MRI Study
- (2014) Campbell J Le Heron et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease?
- (2014) Roberto Erro et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Dopamine receptor mapping with PET imaging in Parkinson’s disease
- (2014) Flavia Niccolini et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
- (2014) H.-F. Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia
- (2014) J Kuhn et al. MOLECULAR PSYCHIATRY
- Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci
- (2014) O A Andreassen et al. MOLECULAR PSYCHIATRY
- The neurobiological basis of cognitive impairment in Parkinson's disease
- (2014) Glenda M. Halliday et al. MOVEMENT DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Neuroimaging in Parkinson disease: from research setting to clinical practice
- (2014) Marios Politis Nature Reviews Neurology
- Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment
- (2014) David R. Whitfield et al. NEUROBIOLOGY OF AGING
- Predictors of dementia in Parkinson disease: A prospective cohort study
- (2014) J. B. M. Anang et al. NEUROLOGY
- Functional connectivity and cognitive decline over 3 years in Parkinson disease
- (2014) K. T. E. Olde Dubbelink et al. NEUROLOGY
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease
- (2014) Monika Białecka et al. NEUROSCIENCE LETTERS
- Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease
- (2014) Nagaendran Kandiah et al. PARKINSONISM & RELATED DISORDERS
- Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
- (2014) Irena Rektorova et al. PLoS One
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study
- (2014) Marta Marquie et al. Alzheimers Research & Therapy
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
- (2014) Ignacio F. Mata et al. JAMA Neurology
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
- (2013) Sophie E. Winder-Rhodes et al. BRAIN
- Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment
- (2013) Daniel Lindqvist et al. BRAIN BEHAVIOR AND IMMUNITY
- Comparison of quantitative EEG between patients with Alzheimer’s disease and those with Parkinson’s disease dementia
- (2013) Lineu C. Fonseca et al. CLINICAL NEUROPHYSIOLOGY
- Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
- (2013) K. D. van Dijk et al. EUROPEAN JOURNAL OF NEUROLOGY
- No Association between Brain-Derived Neurotrophic Factor G196A Polymorphism and Clinical Features of Parkinson's Disease
- (2013) Marina Svetel et al. EUROPEAN NEUROLOGY
- Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage
- (2013) Federica Agosta et al. HUMAN BRAIN MAPPING
- Cortical thinning is associated with disease stages and dementia in Parkinson's disease
- (2013) M. Zarei et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease
- (2013) J. E. Lee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
- (2013) Caroline H Williams-Gray et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease
- (2013) Natália Pessoa Rocha et al. MOVEMENT DISORDERS
- Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease
- (2013) Mona K. Beyer et al. MOVEMENT DISORDERS
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Evolution of mild cognitive impairment in Parkinson disease
- (2013) M. Broeders et al. NEUROLOGY
- The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
- (2013) James Gratwicke et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population
- (2013) Kun Nie et al. NEUROSCIENCE LETTERS
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
- (2013) Javier Pagonabarraga et al. PLoS One
- Prognosis of Mild Cognitive Impairment in Early Parkinson Disease
- (2013) Kenn Freddy Pedersen et al. JAMA Neurology
- Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs WithoutGBAMutations
- (2013) Lama M. Chahine et al. JAMA Neurology
- An FP-CIT PET Comparison of the Differences in Dopaminergic Neuronal Loss Between Idiopathic Parkinson Disease With Dementia and Without Dementia
- (2012) In-Uk Song et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson’s disease: a PET study
- (2012) Kit Wu et al. BRAIN
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Cholinergic Deficit and Response to Donepezil Therapy in Parkinsons Disease with Dementia
- (2012) Kotaro Hiraoka et al. EUROPEAN NEUROLOGY
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia
- (2012) Nicolaas I Bohnen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture
- (2012) Natasha Bajic et al. JOURNAL OF NEURAL TRANSMISSION
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
- (2012) Per Svenningsson et al. LANCET NEUROLOGY
- Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
- (2012) R Killick et al. MOLECULAR PSYCHIATRY
- Genetic influences on cognitive decline in Parkinson's disease
- (2012) James F. Morley et al. MOVEMENT DISORDERS
- Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study
- (2012) Bruno Dubois et al. MOVEMENT DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- A large study reveals no association between APOE and Parkinson's disease
- (2012) Monica Federoff et al. NEUROBIOLOGY OF DISEASE
- Default Mode Network and Extrastriate Visual Resting State Network in Patients with Parkinsons Disease Dementia
- (2012) I. Rektorova et al. Neurodegenerative Diseases
- Cognitive Impairment in Parkinsons Disease: The Dual Syndrome Hypothesis
- (2012) Angie A. Kehagia et al. Neurodegenerative Diseases
- Lower cognitive performance in healthy G2019S LRRK2 mutation carriers
- (2012) A. Thaler et al. NEUROLOGY
- A -amyloid deposition in patients with Parkinson disease at risk for development of dementia
- (2012) M. Petrou et al. NEUROLOGY
- Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study
- (2012) G. A. Carlesimo et al. NEUROLOGY
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- (2012) S. N. Gomperts et al. NEUROLOGY
- Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study
- (2012) R. N. Alcalay et al. NEUROLOGY
- Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders
- (2012) Vikas Kotagal et al. NEUROSCIENCE LETTERS
- Genomic determinants of motor and cognitive outcomes in Parkinson’s disease
- (2012) Sun Ju Chung et al. PARKINSONISM & RELATED DISORDERS
- Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
- (2012) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Interregional Correlations in Parkinson Disease and Parkinson-related Dementia with Resting Functional MR Imaging
- (2012) Tyler M. Seibert et al. RADIOLOGY
- Imaging of microglia in patients with neurodegenerative disorders
- (2012) Marios Politis Frontiers in Pharmacology
- Dementia Risk in Parkinson Disease
- (2011) Núria Setó-Salvia et al. ARCHIVES OF NEUROLOGY
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Clinical EEG in cognitively impaired patients with Parkinson's Disease
- (2011) Nina Schlede et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)
- (2011) Johanne H. Somme et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Synaptic Protein Alterations in Parkinson’s Disease
- (2011) Ilse S. Pienaar et al. MOLECULAR NEUROBIOLOGY
- Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease
- (2011) Vicki Shanker et al. MOVEMENT DISORDERS
- Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
- (2011) Núria Setó-Salvia et al. MOVEMENT DISORDERS
- Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
- (2011) Annika Öhrfelt et al. NEUROCHEMICAL RESEARCH
- Multimodal classification of Alzheimer's disease and mild cognitive impairment
- (2011) Daoqiang Zhang et al. NEUROIMAGE
- Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism
- (2011) S. Pappata et al. NEUROLOGY
- Quantitative EEG as a predictive biomarker for Parkinson disease dementia
- (2011) B. T. Klassen et al. NEUROLOGY
- Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
- (2011) Samia Ben Sassi et al. PARKINSONISM & RELATED DISORDERS
- Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease
- (2010) L. Gao et al. ACTA NEUROLOGICA SCANDINAVICA
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Errata
- (2010) Kay Seidel et al. ANNALS OF NEUROLOGY
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease
- (2010) Roy N. Alcalay et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Quantitative EEG Analysis of Executive Dysfunction in Parkinson Disease
- (2010) Satoshi Kamei et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- (2010) D. Weintraub et al. NEUROLOGY
- Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
- (2010) J. C. Klein et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
- (2010) Soreya Belarbi et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
- (2009) Caroline H. Williams-Gray et al. BRAIN
- Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson’s disease
- (2009) Naroa Ibarretxe-Bilbao et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
- (2009) Martin Wilhelm Kurz et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease
- (2009) C. H. Williams-Gray et al. JOURNAL OF NEUROLOGY
- Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
- (2009) U. Ehrt et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
- (2009) H. Shimada et al. NEUROLOGY
- A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
- (2009) Andreas Puschmann et al. PARKINSONISM & RELATED DISORDERS
- Attentional control in Parkinson's disease is dependent on COMT val158met genotype
- (2008) C. H. Williams-Gray et al. BRAIN
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- [11C]PIB binding in Parkinson's disease dementia
- (2007) Walter Maetzler et al. NEUROIMAGE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started